Literature DB >> 23324584

Diagnostic use of serum ferritin levels to differentiate infectious and noninfectious diseases in patients with fever of unknown origin.

Seong Eun Kim1, Uh Jin Kim, Mi Ok Jang, Seung Ji Kang, Hee Chang Jang, Sook In Jung, Shin Seok Lee, Kyung Hwa Park.   

Abstract

INTRODUCTION: In this study, we determined whether serum ferritin levels could be used to differentiate between fever of unknown origin (FUO) caused by infectious and noninfectious diseases.
METHODS: FUO patients were hospitalized at Chonnam National University Hospital between January, 2005 and December, 2011. According to the final diagnoses, five causes were identified, including infectious diseases, hematologic diseases, noninfectious inflammatory diseases, miscellaneous and undiagnosed.
RESULTS: Of the 77 patients, 11 were caused by infectious diseases, 13 by hematologic diseases, 20 by noninfectious inflammatory diseases, 8 by miscellaneous diseases, and 25 were undiagnosed. The median serum ferritin levels in infectious diseases was lower than those in hematologic diseases and (median (interquartile range) of 282.4 (149.0-951.8) ng/mL for the infectious disease group, 1818.2 (485.4-4789.5) ng/mL for the hematologic disease group, and 563.7 (399.6-1927.2) ng/mL for the noninfectious inflammatory disease group, p=0.048, Kruskal-Wallis test). By comparison using the Mann-Whitney test, statistically significant differences were found only between the infectious disease and hematologic disease groups (p=0.049) and between the infectious disease and groups (p=0.04).
CONCLUSION: An optimal cutoff value of serum ferritin levels to predict FUO caused by a noninfectious disease (hematologic diseases, noninfectious inflammatory diseases) was established as 561 ng/mL.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23324584      PMCID: PMC3810234          DOI: 10.3233/DMA-130962

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  8 in total

1.  Establishment of a Predictive Model Related to Pathogen Invasion for Infectious Diseases and Its Diagnostic Value in Fever of Unknown Origin.

Authors:  Zhu-Hua Wu; Ming-You Xing; Sheng Wei; Man-Zhi Zhao; Wen-Xia Wang; Lin Zhu; Ji-Ling Zhu; Cai-Feng Zheng; Si-Jun Wang; Jun-Ying Qi; Jian-Xin Song
Journal:  Curr Med Sci       Date:  2018-12-07

2.  Fever with persistent flagellate erythema in a primigravida: a rare presentation of adult-onset Still's disease.

Authors:  Riti Bhatia; Nidhi Kaeley; Ravi Kant; Ankith Basi
Journal:  BMJ Case Rep       Date:  2019-07-12

3.  Non-SARS-CoV-2 Infections Among Patients Evaluated for MIS-C Associated With COVID-19.

Authors:  Jeffrey I Campbell; Jordan E Roberts; Melanie Dubois; Caitlin Naureckas Li; Thomas J Sandora; Gabriella S Lamb
Journal:  Pediatr Infect Dis J       Date:  2021-02-01       Impact factor: 3.806

4.  Hyperferritinemia as a Diagnostic Marker for Severe Fever with Thrombocytopenia Syndrome.

Authors:  Uh Jin Kim; Tae Hoon Oh; Bansuk Kim; Seong Eun Kim; Seung-Ji Kang; Kyung-Hwa Park; Sook-In Jung; Hee-Chang Jang
Journal:  Dis Markers       Date:  2017-02-28       Impact factor: 3.434

5.  Fever of Unknown Origin: The Workup and Diagnosis of Pel-Ebstein Fever.

Authors:  Prachi Khanna; Natalie Malluru; Raaj Pyada; Mitul Gupta; Kartik Akkihal; Thomas C Varkey
Journal:  Cureus       Date:  2022-02-06

6.  Diagnostic utility of clinical characteristics, laboratory tests, and serum ferritin in diagnosis of adult-onset Still disease.

Authors:  Iftach Sagy; Alona Finkel-Oron; Eviatar Naamany; Leonid Barski; Mahmoud Abu-Shakra; Yair Molad; Shachaf Shiber
Journal:  Medicine (Baltimore)       Date:  2022-08-26       Impact factor: 1.817

7.  Serum ferritin and primary lung cancer.

Authors:  Zhongqing Chen; Bo Zhu; Chao Ou; Yuxuan Li
Journal:  Oncotarget       Date:  2017-10-04

8.  Hyperferritinemia in the elderly can differentiate the bad from the worst: A retrospective cohort analysis.

Authors:  Gal Goldhaber; Gad Segal; Amir Dagan
Journal:  Medicine (Baltimore)       Date:  2020-07-31       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.